Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol

Autor: Sara Bonet Monne, Betlem Salvador-Gonzalez, Jesús Almeda Ortega, Ramon Monfà Escolà, Gemma Alvarez Muñoz, Sara Contreras-Martos, Marina Balanzó Joué, Francisco Mera-Cordero, Ana García-Sangenís, Rosa Morros Pedrós, Oriol Cunillera Puértolas

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Trials
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Trials, Vol 23, Iss 1, Pp 1-9 (2022)

Background The coronavirus disease 2019 (COVID-19) pandemic continues to affect the globe. After 18 months of the SARS-CoV-2 emergence, clinicians have clearly defined a subgroup of patients with lasting, disabling symptoms. While big strides have be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324a2e93b5db28719d1bfb34ba56c0e7
http://hdl.handle.net/2445/182836